BioCurex, Inc.(fka BOCX)

[Gold Seeker]

The following is conjecture on my part. Those that do not want to read it, please skip the message or put me on ignore.


We know that Moro stated the test is complex.
We know that it requires "know how" to run and cannot be duplicated by someone trying to rip off the patent.
We know that the company stated that they needed a colorimetric format.
All of the above was either sourced from press releases or from contact with the company within the last 6 months.

Now we know that the company has expended the effort to develop a colorimetry test that does work and is much more effective than a PSA test.
We know that Moro was at a convention demonstrating the success of the colorimetric test.
My guess is that they are presently attempting to license a stand alone colorimetric test and they may have one or more interested parties. The current push for funding is a hedge against the possibility of Abbott returning the test. We are probably approaching the point when Abbott is going to have to pay the company a minimum royalty payment. I am guessing that the cut off date to avoid the payment would be Dec 29th. The company needed enough money on hand to continue operations and license the stand alone test because a return of the license by Abbott would decimate the stock. I am not saying that the test will be returned but the company is executing a plan to have enough cash on hand to remain in operation in that event. IMO, that would be a very prudent precaution.